Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.47 |
| ▸ | MANBA | O00462 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | THPO | P40225 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | GLB1 | P16278 | 1/20 | 0.32 |
| ▸ | MGAM | O43451 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4141870 | 1.00 | LMNA (0.47) | LMNAHIF1AMANBATHRBCYP1A2 | |
| SCHEMBL13106543 | 1.00 | LMNA (0.47) | LMNAHIF1AMANBATHRBCYP1A2 | |
| SCHEMBL19146568 | 1.00 | LMNA (0.47) | LMNAHIF1AMANBATHRBCYP1A2 | |
| SCHEMBL4131205 | 1.00 | LMNA (0.47) | LMNAHIF1AMANBATHRBCYP1A2 | |
| SCHEMBL19146746 | 1.00 | LMNA (0.47) | LMNAHIF1AMANBATHRBCYP1A2 | |
| SCHEMBL23288111 | 1.00 | LMNA (0.47) | LMNAHIF1AMANBATHRBCYP1A2 | |
| SCHEMBL19129777 | 1.00 | LMNA (0.47) | LMNAHIF1AMANBATHRBCYP1A2 | |
| SCHEMBL19129720 | 1.00 | LMNA (0.47) | LMNAHIF1AMANBATHRBCYP1A2 | |
| SCHEMBL12396147 | 1.00 | LMNA (0.47) | LMNAHIF1AMANBATHRBCYP1A2 | |
| SCHEMBL13772994 | 0.89 | MANBA (0.36) | LMNAHIF1AMANBATHRBMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4861892-A | Method for synthesis of deoxymannojirimycin | G. D. SEARLE & CO. (US) | 1989-08-29 | — | — | US | claimed |
| EP-0328508-A2 | Method for synthesis of deoxymannojirimycin | The NutraSweet Company (US) | 1989-08-16 | — | — | EP | claimed |
| US-9089515-B2 | Long chain N-alkyl compounds and oxa-derivatives thereof | THOMAS JEFFERSON UNIVERSITY (US) | 2015-07-28 | — | — | US | disclosed |
| US-9089515-B2 | Long chain N-alkyl compounds and oxa-derivatives thereof | THOMAS JEFFERSON UNIVERSITY (US) | 2015-07-28 | — | — | US | disclosed |
| US-20110184019-A1 | Long chain N-Alkyl compounds and oxa-derivatives thereof | THOMAS JEFFERSON UNIVERSITY | 2011-07-28 | — | — | US | disclosed |
| US-7816560-B1 | Long chain n-alkyl compounds and oxa-derivatives thereof | THOMAS JEFFERSON UNIVERSITY (US) | 2010-10-19 | — | — | US | disclosed |
| US-7816560-B1 | Long chain n-alkyl compounds and oxa-derivatives thereof | THOMAS JEFFERSON UNIVERSITY (US) | 2010-10-19 | — | — | US | disclosed |
| US-20100137365-A1 | Long chain N-alkyl compounds and oxa-derivatives thereof | THOMAS JEFFERSON UNIVERSITY | 2010-06-03 | — | — | US | disclosed |
| US-20100137365-A1 | Long chain N-alkyl compounds and oxa-derivatives thereof | THOMAS JEFFERSON UNIVERSITY | 2010-06-03 | — | — | US | disclosed |
| EP-1210082-B1 | LONG CHAIN N-ALKYL COMPOUNDS AND OXA-DERIVATIVES THEREOF AND USE AS ANTIVIRAL COMPOSITIONS | UNIV OXFORD (GB) | 2008-01-02 | — | — | EP | disclosed |
| US-6562514-B1 | Stabilized vanadium electrolyte solutions for all-vanadium redox cells and batteries | PINNACLE VRB LIMITED (AU) | 2003-05-13 | — | — | US | disclosed |
| US-6143443-A | ALL-VANADIUM REDOX BATTERY, COMPRISING THE STABILIZED ELECTROLYTE | PINNACLE ARB LIMITED (AU) | 2000-11-07 | — | — | US | disclosed |
| EP-0829104-A1 | HIGH ENERGY DENSITY VANADIUM ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND ALL-VANADIUM REDOX CELLS AND BATTERIES CONTAINING HIGH ENERGY VANADIUM ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1998-03-18 | — | — | EP | disclosed |
| US-5210089-A | Alpha and beta-mannosidase inhibitors | MONSANTO COMPANY (US) | 1993-05-11 | — | — | US | disclosed |
| EP-0328508-A3 | METHOD FOR SYNTHESIS OF DEOXYMANNOJIRIMYCIN | The NutraSweet Company (US) | 1992-03-04 | — | — | EP | disclosed |
| US-4861892-A | Method for synthesis of deoxymannojirimycin | G. D. SEARLE & CO. (US) | 1989-08-29 | — | — | US | disclosed |
| US-4861892-A | Method for synthesis of deoxymannojirimycin | G. D. SEARLE & CO. (US) | 1989-08-29 | — | — | US | disclosed |
| EP-0328508-A2 | Method for synthesis of deoxymannojirimycin | The NutraSweet Company (US) | 1989-08-16 | — | — | EP | disclosed |
| EP-0328508-A2 | Method for synthesis of deoxymannojirimycin | The NutraSweet Company (US) | 1989-08-16 | — | — | EP | disclosed |
| US-4111958-A | Ascorbic acid synthesis | PFIZER INC. (US) | 1978-09-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100137365-A1 | Long chain N-alkyl compounds and oxa-derivatives thereof | OXA1L, OTC, PAICS | LMNA 534/4885HIF1A 3649/4885MANBA 4339/4885 |
| US-20110184019-A1 | Long chain N-Alkyl compounds and oxa-derivatives thereof | OXA1L, OTC, PAICS | LMNA 534/4885HIF1A 3649/4885MANBA 4339/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.